期刊文献+

川崎病并发冠状动脉病变研究进展 被引量:9

Progress in Kawasaki disease with coronary artery lesions
原文传递
导出
摘要 川崎病是一种原因未明的急性全身血管炎性疾病,其主要并发症为冠状动脉病变,包括冠状动脉扩张、冠状动脉瘤形成等,且急性期过后冠状动脉损害持续存在。近年来研究表明,基因多态性、中性粒细胞、单核细胞、细胞因子等多种因素共同参与了冠状动脉病变的形成,长期抗凝药物的使用可降低冠状动脉损害。 Kawasaki.ki disease, which is an acute multisystem vasculitis of unknown cause, leads to pathognomonic feature of coronary artery lesion. Recent studies show that genetic polymorphism, neutrophils, monocytes, cytokines and other factors are involved in the development of coronary artery disease. Long-term use of anticoagulant drugs may reduce coronary artery damage.
出处 《国际儿科学杂志》 2012年第2期135-138,共4页 International Journal of Pediatrics
基金 国家自然科学基金资助项目(30973223)
关键词 皮肤黏膜淋巴结综合征 冠状动脉病变 Mucocutaneous lymphnode syndrome Coronary artery lesion
  • 相关文献

参考文献31

  • 1张永兰,杜忠东.川崎病并发冠状动脉损害的危险因素[J].国际儿科学杂志,2006,33(2):93-96. 被引量:23
  • 2吴衍文,陈少华,王弘.川崎病冠状动脉损害危险因素分析[J].中国小儿急救医学,2011,18(3):260-262. 被引量:18
  • 3Hui-Yuen JS,Duong TT, Yeung RS. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J lmmunol,2006,176 ( 10 ) : 6294-6301.
  • 4Cheung YF,Huang GY, Chen SB, et al. Inflammatory gene poly- morphisms and susceptibility to kawasaki disease and its arterial se- quelae. Pediatrics ,2008,122 ( 3 ) : e608-614.
  • 5Huang FY, Chang TY, Chen MR, et al. Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasa- ki disease in Taiwan Residents children. J Clin Immuno1,2008,28 (4) :322- 328.
  • 6Lau AC, Duong TT, Ito S, et al. Inhibition of matrix metalloprotein- ase-9 activity improves coronary outcome in. an animal model of Kawasaki disease. Clin Exp Immuno1,2009,157 (2) :300-309.
  • 7Shimizu C,Matsubara T, Onouchi Y, et al. Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawaski disease. J Hum Genet, 2010,55 ( 12 ) : 779- 784.
  • 8Kuo HC, Liang CD, Yu HR, et al. CTLA-4, Position 49 A/G poly- morphism associated with coronary artery lesions in kawasaki dis- ease. J Clin Immunol,2011,31 (2) :240-244.
  • 9Park SW,BanJY, Yoon KL, et al. Involvement of tryptophan hydroxylase 2 (TPH2) gene polymorphisms in susceptibility to coro- nary artery lesions in Kawasaki disease. Eur J Pediatr, 2010, 169 (4) :457-461.
  • 10Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymoro phism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet,2008,40( 1 ) :35-42.

二级参考文献52

  • 1黄国英.川崎病流行病学现状[J].中国实用儿科杂志,2006,21(10):721-723. 被引量:46
  • 2沈伟,杨默,李晋蜀,简玲.川崎病血小板增多的可能原因及机制[J].中华血液学杂志,2007,28(5):359-360. 被引量:15
  • 3Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis,treatment, and long-term management of Kawasaki disease: a statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2004, 110: 2747-2771.
  • 4Suzuki A, Miyagawa-Tomita S, Nakazawa M, et al. Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohisto -chemical findings. Jpn Heart J, 2000 ,41:245-256.
  • 5Thelen M. Dancing to the tune of chemokines. Nat Immunol, 2001,2 : 129-134.
  • 6Mannhalter C, Koizar D, Mitterbauer G. Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA. Clin Chem Lab Med, 2000,38: 171-177.
  • 7Hiasa K, Ishibashi M, Ohtani K, et al. Gene transfer of stromal cell-derived factor-1 [ alpha] enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation, 2004,109 : 2454 -2461.
  • 8Kumar SN, Boss JM. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1. Mol Immunol, 2000, 37,623-632.
  • 9龚非力.基础免疫学.武汉:湖北科学技术出版社,2002:149.
  • 10Terai M, Jibiki T, Harada A, et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol, 1999, 65: 566-572.

共引文献54

同被引文献150

引证文献9

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部